1. Home
  2. MDXH vs VERI Comparison

MDXH vs VERI Comparison

Compare MDXH & VERI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDXH
  • VERI
  • Stock Information
  • Founded
  • MDXH 2003
  • VERI 2014
  • Country
  • MDXH Belgium
  • VERI United States
  • Employees
  • MDXH N/A
  • VERI N/A
  • Industry
  • MDXH
  • VERI EDP Services
  • Sector
  • MDXH
  • VERI Technology
  • Exchange
  • MDXH Nasdaq
  • VERI Nasdaq
  • Market Cap
  • MDXH 141.1M
  • VERI 145.4M
  • IPO Year
  • MDXH 2021
  • VERI 2017
  • Fundamental
  • Price
  • MDXH $4.52
  • VERI $5.03
  • Analyst Decision
  • MDXH Buy
  • VERI Strong Buy
  • Analyst Count
  • MDXH 1
  • VERI 4
  • Target Price
  • MDXH $6.00
  • VERI $9.75
  • AVG Volume (30 Days)
  • MDXH 189.5K
  • VERI 8.1M
  • Earning Date
  • MDXH 11-05-2025
  • VERI 11-11-2025
  • Dividend Yield
  • MDXH N/A
  • VERI N/A
  • EPS Growth
  • MDXH N/A
  • VERI N/A
  • EPS
  • MDXH N/A
  • VERI N/A
  • Revenue
  • MDXH $98,953,000.00
  • VERI $90,902,000.00
  • Revenue This Year
  • MDXH $24.40
  • VERI $19.12
  • Revenue Next Year
  • MDXH $22.29
  • VERI $17.82
  • P/E Ratio
  • MDXH N/A
  • VERI N/A
  • Revenue Growth
  • MDXH 22.56
  • VERI N/A
  • 52 Week Low
  • MDXH $1.35
  • VERI $1.22
  • 52 Week High
  • MDXH $4.94
  • VERI $6.43
  • Technical
  • Relative Strength Index (RSI)
  • MDXH 69.80
  • VERI 59.86
  • Support Level
  • MDXH $4.60
  • VERI $4.56
  • Resistance Level
  • MDXH $4.94
  • VERI $5.83
  • Average True Range (ATR)
  • MDXH 0.27
  • VERI 0.59
  • MACD
  • MDXH -0.02
  • VERI -0.05
  • Stochastic Oscillator
  • MDXH 75.33
  • VERI 41.65

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.

About VERI Veritone Inc.

Veritone Inc is a provider of artificial intelligence (AI) computing solutions and services. It generates revenue through the delivery of its Software Products and Services which consists of revenues generated from Commercial Enterprise and Government and Regulated Industries customers using the company's aiWARE platform and hiring solutions, any related support and maintenance services, and any related professional services associated with the deployment and/or implementation of such solutions, Managed Services which consist of revenues generated from Commercial Enterprise customers using company's content licensing services, advertising agency, influencer management and related services. It has a presence in the United States, the United Kingdom, France, Australia, Israel, and India.

Share on Social Networks: